Schneider Innovation Center

Schneider Innovation Center sits inside Schneider Children’s Medical Center, Israel’s only comprehensive pediatric hospital, and operates as a dedicated innovation hub for child-centric medical technology. The clinical context is the asset, and the program is structured around it.

The thesis is grounded in the reality that pediatric medicine is structurally different from adult medicine, and most healthcare innovation systematically ignores it. Schneider’s program exists to address that gap, providing entrepreneurs access to the only pediatric-focused comprehensive clinical environment in the country. Portfolio activity concentrates on digital health and medical devices, with attention to pediatric monitoring, diagnostics, surgical and procedural devices, and digital health products designed for children, families, and pediatric clinical workflows. AI is increasingly relevant across the portfolio as pediatric data and clinical decision-making become amenable to machine learning approaches that respect the unique developmental and physiological characteristics of children.

Checks fall below two hundred and fifty thousand dollars at the Pre-Seed and Seed stages, structured to underwrite early commercialization and clinical validation work. Geography is anchored in companies engaging with Schneider clinicians and the hospital’s clinical environment, with portfolio companies typically targeting global pediatric markets in the US and Europe. The program is positioned as the natural starting point for pediatric-focused medical innovation in Israel, and successful companies are expected to graduate into institutional venture capital with credible clinical evidence already in hand.

The team operates at the intersection of pediatric clinical practice and commercial development. Founders engage with pediatric specialists, clinical staff, and program leadership, and the diligence is heavy on clinical defensibility, pediatric-specific regulatory pathway, and the operational reality of how a product would be used in a pediatric environment. The relationships within Schneider itself are the program’s distinctive asset, providing clinical evidence, KOL development, and the kind of access to real pediatric workflows that founders cannot otherwise assemble.

In practice, the value-add concentrates on the parts of pediatric healthcare innovation that are genuinely hard. That includes navigating the regulatory specifics of pediatric devices and software, building clinical evidence in a population that is harder to study than adults, and designing products that work in pediatric clinical workflows that look meaningfully different from adult care. Schneider is direct about scope. It does not invest in companies disconnected from pediatric medicine, and it is not a generalist healthcare program. For founders building pediatric-focused digital health and medical device products, Schneider Innovation Center is the most substantive early-stage program in the country and one of a small number globally with this depth of pediatric clinical access. The conversations are clinically rigorous, the engagement is hands-on, and the founders who do well treat the program as a structured partnership with the only pediatric hospital they will need at this stage of company building.